Atlas Trials

Study to Investigate the Safety and Efficacy of Ranibizumab in Patients With Choroidal Neovascularisation Due to Causes Other Than Age Related Macular Degeneration

Clinical trial NCT01628354 · COMPLETED

Trial details

NCT number
NCT01628354
Sponsor
University of Melbourne
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Choroidal NeovascularizationRetinal Pigment Epithelial Detachment
Start date
2008-02-01
Primary completion
2010-04-01
Enrollment
49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.